Several other equities analysts have also recently commented on ITGR. Zacks Investment Research cut shares of Integer from a strong-buy rating to a hold rating in a research note on Monday, January 7th. Royal Bank of Canada boosted their price objective on shares of Integer from $84.00 to $92.00 and gave the company a sector perform rating in a research note on Monday, February 25th. Two analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of Buy and an average target price of $89.40.
Shares of NYSE:ITGR opened at $70.89 on Thursday. The company has a market cap of $2.31 billion, a P/E ratio of 18.66 and a beta of 0.98. Integer has a 12 month low of $54.20 and a 12 month high of $92.61. The company has a debt-to-equity ratio of 0.84, a current ratio of 2.53 and a quick ratio of 1.37.
In related news, SVP Anthony W. Borowicz sold 2,500 shares of the business’s stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $85.92, for a total transaction of $214,800.00. Following the completion of the transaction, the senior vice president now owns 18,124 shares of the company’s stock, valued at $1,557,214.08. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Donald J. Spence sold 50,559 shares of the business’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $85.41, for a total transaction of $4,318,244.19. Following the completion of the transaction, the director now directly owns 41,285 shares of the company’s stock, valued at approximately $3,526,151.85. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 62,147 shares of company stock valued at $5,358,962. 2.24% of the stock is owned by corporate insiders.
A number of hedge funds have recently added to or reduced their stakes in ITGR. FMR LLC purchased a new position in Integer in the 3rd quarter worth approximately $36,552,000. Norges Bank purchased a new position in Integer in the 4th quarter worth approximately $30,458,000. American Century Companies Inc. grew its stake in Integer by 158.3% in the 4th quarter. American Century Companies Inc. now owns 379,748 shares of the medical equipment provider’s stock worth $28,960,000 after buying an additional 232,702 shares in the last quarter. Renaissance Technologies LLC grew its stake in Integer by 199.4% in the 3rd quarter. Renaissance Technologies LLC now owns 235,300 shares of the medical equipment provider’s stock worth $19,518,000 after buying an additional 156,700 shares in the last quarter. Finally, WINTON GROUP Ltd purchased a new position in Integer in the 4th quarter worth approximately $10,747,000. 95.80% of the stock is owned by institutional investors and hedge funds.
Integer Company Profile
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.
Further Reading: What is a Lock-Up Period?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.